Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Lion Biotechnologies Inc (LBIO) About to Roar?

Consequently, specific money managers have jumped into Lion Biotechnologies Inc (NASDAQ:LBIO) headfirst. Sabby Capital, managed by Hal Mintz, created the biggest call position in Lion Biotechnologies Inc (NASDAQ:LBIO). Sabby Capital had $0.4 million invested in the company at the end of the quarter. Jim Simons’ Renaissance Technologies also initiated a $0.2 million position during the quarter. The following funds were also among the new LBIO investors: Matthew Tewksbury’s Stevens Capital Management, Ken Griffin’s Citadel Investment Group, and Mike Vranos’ Ellington.

Let’s go over hedge fund activity in other stocks – not necessarily in the same industry as Lion Biotechnologies Inc (NASDAQ:LBIO) but similarly valued. We will take a look at REX American Resources Corp (NYSE:REX), Dorian LPG Ltd (NYSE:LPG), Exar Corporation (NASDAQ:EXAR), and Vicor Corp (NASDAQ:VICR). This group of stocks’ market values are closest to LBIO’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
REX 8 68306 2
LPG 8 56727 -2
EXAR 14 74142 -1
VICR 6 14868 -2

As you can see these stocks had an average of 9 hedge funds with bullish positions and the average amount invested in these stocks was $54 million. That figure was $163 million in LBIO’s case. Exar Corporation (NASDAQ:EXAR) is the most popular stock in this table. On the other hand Vicor Corp (NASDAQ:VICR) is the least popular one with only 6 bullish hedge fund positions. Compared to these stocks Lion Biotechnologies Inc (NASDAQ:LBIO) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers and have more money invested in it, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.